Search - tctmd.com

Displaying 21 - 40 of 40

Sort: Relevancy | Date

News Opinion Off Script AHA 2019

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

Ajay Kirtane, MD, SM

November 12, 2019

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Shelley Wood

November 11, 2019

News Conference News AHA 2019

ISCHEMIA Countdown Begins, but a ‘Black-and-White’ Answer Is Uncertain

Shelley Wood

October 25, 2019

News Conference News AHA 2017

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

Michael O'Riordan

November 21, 2017

News Conference News AHA 2017

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Michael O'Riordan

November 13, 2017

News Conference News AHA 2017

Angiography, Revascularization Safe in Acute MI Patients Taking OACs for Atrial Fibrillation

Michael O'Riordan

November 13, 2017

Presentation AHA 2017

Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial

Presenter: Steven Weisbord

November 13, 2017

News Conference News AHA 2017

PRESERVE Puts the Kibosh on Approaches to Preventing Contrast-Associated AKI

Todd Neale

November 12, 2017

News Conference News AHA 2016

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Shelley Wood

November 28, 2016

News Conference News AHA 2016

商业健康保险的年轻患者的压力测试可能会增加

L.A. McKeown

November 23, 2016

News Conference News AHA 2016

Stress Testing May Be Increasing Among Younger Patients With Commercial Health Insurance

L.A. McKeown

November 23, 2016

News Conference News AHA 2016

La Pruebas de Esfuerzo podrían estar Aumentando en Pacientes Más Jóvenes con Seguro Médico Comercial

L.A. McKeown

November 23, 2016

News Conference News AHA 2016

PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad

Michael O'Riordan

November 15, 2016

Presentation AHA 2016

GLAGOV Trial: Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound

Presenter: Steven E. Nissen

November 15, 2016

Presentation AHA 2016

FUnctional Testing Underlying REvascularization: The FUTURE trial

Presenter: Gilles Rioufol

November 15, 2016

News Conference News AHA 2016

Incomplete Revascularization Linked With Increased MACE in Subsequent Noncardiac Surgery

Michael O'Riordan

November 15, 2016

News Conference News AHA 2016

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

Michael O'Riordan

November 14, 2016

News Conference News AHA 2016

Secondhand Smoke Exposure Associated With Increased Risk of Coronary Atherosclerosis

Michael O'Riordan

November 13, 2016

News Conference News AHA 2016

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Shelley Wood

November 09, 2016

News Conference News AHA 2013

French Registry: FFR Safely Reclassifies Almost Half of Revascularization Patients

Yael L. Maxwell

November 20, 2013

Advertisement

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

ISCHEMIA Countdown Begins, but a ‘Black-and-White’ Answer Is Uncertain

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Angiography, Revascularization Safe in Acute MI Patients Taking OACs for Atrial Fibrillation

Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial

PRESERVE Puts the Kibosh on Approaches to Preventing Contrast-Associated AKI

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

商业健康保险的年轻患者的压力测试可能会增加

Stress Testing May Be Increasing Among Younger Patients With Commercial Health Insurance

La Pruebas de Esfuerzo podrían estar Aumentando en Pacientes Más Jóvenes con Seguro Médico Comercial

PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad

GLAGOV Trial: Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound

FUnctional Testing Underlying REvascularization: The FUTURE trial

Incomplete Revascularization Linked With Increased MACE in Subsequent Noncardiac Surgery

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

Secondhand Smoke Exposure Associated With Increased Risk of Coronary Atherosclerosis

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

French Registry: FFR Safely Reclassifies Almost Half of Revascularization Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content